Epigenetic inhibitors sensitize DLBCL cells to rituximab and doxorubicin
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP182909
下载链接
链接失效反馈官方服务：
资源简介：
In this study we tested 60 epigenetic inhibitors on four DLBCL cell lines to invesitage whether epigenetic reprogramming can induce sensitization towards rituximab and doxorubicin. The exome and transcriptome data uploaded here were then generated to investigate the mechanisms behind the epigenetic reprogramming leading to sensitization.
创建时间：
2020-03-02
